Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $181.86 | 6 | 91.8% |
| Education | $16.14 | 1 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI PASTEUR INC. | $96.85 | 4 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $50.01 | 1 | $0 (2020) |
| Janssen Biotech, Inc. | $35.00 | 1 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $16.14 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.50 | 2 | SANOFI PASTEUR INC. ($50.50) |
| 2023 | $46.35 | 2 | SANOFI PASTEUR INC. ($46.35) |
| 2020 | $101.15 | 3 | Pharmacyclics LLC, An AbbVie Company ($50.01) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/22/2024 | SANOFI PASTEUR INC. | MENQUADFI (Biological), VAXELIS | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Vaccines | ||||||
| 02/01/2024 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), BEYFORTUS, MENQUADFI | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Vaccines | ||||||
| 11/02/2023 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), BEYFORTUS | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Vaccines | ||||||
| 08/15/2023 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), BEYFORTUS | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: Vaccines | ||||||
| 07/13/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $16.14 | General |
| Category: Oncology | ||||||
| 03/07/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $50.01 | General |
| Category: Oncology | ||||||
| 03/07/2020 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 80 | 112 | $17,918 | $4,181 |
| 2020 | 8 | 528 | 1,027 | $179,735 | $61,511 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 54 | 85 | $14,705 | $3,604 | 24.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 26 | 27 | $3,213 | $576.49 | 17.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 186 | 593 | $102,589 | $32,886 | 32.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 61 | 115 | $20,930 | $9,064 | 43.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 155 | 185 | $22,015 | $6,254 | 28.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 35 | 35 | $12,339 | $5,080 | 41.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 50 | 50 | $13,200 | $4,707 | 35.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 17 | $4,046 | $1,762 | 43.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 20 | $2,540 | $1,057 | 41.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 12 | 12 | $2,076 | $701.86 | 33.8% |
About Dr. John Winkelmann, MD
Dr. John Winkelmann, MD is a Hematology & Oncology healthcare provider based in Edgewood, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1144214446.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Winkelmann, MD has received a total of $198.00 in payments from pharmaceutical and medical device companies, with $50.50 received in 2024. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($181.86).
As a Medicare-enrolled provider, Winkelmann has provided services to 608 Medicare beneficiaries, totaling 1,139 services with total Medicare billing of $65,692. Data is available for 2 years (2020–2021), covering 10 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology, Hematology & Oncology
- Location Edgewood, KY
- Active Since 09/01/2005
- Last Updated 05/14/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1144214446
Products in Payments
- FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological) $72.69
- Imbruvica (Drug) $50.01
- DARZALEX (Biological) $35.00
- MENQUADFI (Biological) $24.16
- OPDIVO (Biological) $16.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Edgewood
Matthew Kurian, Md, MD
Hematology & Oncology — Payments: $19,024
Manish Bhandari, M.d, M.D
Hematology & Oncology — Payments: $5,188
Dr. Lawrence Brennan, Md, MD
Hematology & Oncology — Payments: $2,745
Daniel Flora, M.d, M.D
Hematology & Oncology — Payments: $1,416
Dr. Douglas Flora, Md, MD
Hematology & Oncology — Payments: $1,218
Christy Sapp, M.d, M.D
Hematology & Oncology — Payments: $647.20